Catabasis Pharmaceuticals competitors

Catabasis Pharmaceuticals's competitors include Celon Pharma, RespireRx Pharmaceuticals, ACADIA Pharmaceuticals and Adamas Pharmaceuticals
Add company...
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Celon Pharma
Celon Pharma, an integrated pharmaceutical company, researches, manufactures, and sells drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Founding Date
Founding Date
2008
Founding Date
2002
Founding Date
1988
Founding Date
1993
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Kiełpin, PL HQ
Locations
Glen Rock, US HQ
Locations
San Diego, US HQ
Locations
Emeryville, US HQ
Employees
Employees
38
Employees
N/A
Employees
1
Employees
42515% increase
Employees
8415% increase
Valuation ($)
Valuation ($)
26.4 m
Valuation ($)
N/A
Valuation ($)
2.3 m
Valuation ($)
2 b
Valuation ($)
680.2 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$124.9m (FY, 2017)
Revenue (est.)
$572k (FY, 2016)
Net income
Net income
($36.1m) (FY, 2016)
Net income
N/A
Net income
($4.3m) (FY, 2017)
Net income
($289.4m) (FY, 2017)
Net income
($60.1m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 94.9m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 82m
For sources of this data, please see the company profileDownload Excel

View company profiles

Celon Pharma
HQ
Kiełpin, PL

Celon Pharma, an integrated pharmaceutical company, researches, manufactures, and sells drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders.

View company
RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
1

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
425↑ 15% increase

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
84↑ 15% increase

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company